Sign in
4

Changes in Ownership

ADMA BIOLOGICS, INC. Filed Acc 0001140361-26-042166

President and CEO sold 147,000 shares at $12.00 ($1,764,000)

  • President and CEO acquired 105,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Grossman Adam S · President and CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-05 Exercise or conversion : show line 1 in the form 10b5-1 +105,000 $5.40 $567,000 2,217,777 D
2026-11-05 Sale : show line 2 in the form 10b5-1 −105,000 $12.00 $1,260,000 2,112,777 D
2026-11-05 Sale : show line 3 in the form 10b5-1 −42,000 $12.00 $504,000 2,070,777 D
Open-market sales · 147,000 sh · avg $12.00 · $1,764,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-11-05 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) −105,000 585,950 D
Loading xslF345X06/form4.xml…